<DOC>
	<DOCNO>NCT00753675</DOCNO>
	<brief_summary>The primary objective trial determine efficacy VANDETANIB monotherapy VANDETANIB plus GEMCITABINE PLACEBO plus GEMCITABINE prolong progression-free survival ( PFS ) trial closure patient advance ( unresectable metastatic ) biliary tract cancer .</brief_summary>
	<brief_title>Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Gallbladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Histologically cytologicallyconfirmed advanced ( unresectable metastatic ) biliary tract cancer ( gallbladder cancer , cancer extrahepatic bile duct , intrahepatic cholangiocarcinoma ampullary carcinoma ) Patients must measurable evaluable nonmeasurable disease Chemotherapynaïve ( prior chemotherapy adjuvant set complete 3 month trial entry accept ) . WHO performance status 0 2 : patient must WHO PS ≤ 2 Patients must receive prior systemic therapy advance ( unresectable metastatic ) disease ; prior chemotherapy adjuvant set within 3 month trial entry accept Inadequate endorgan function Evidence severe uncontrolled systemic disease concurrent condition Investigator 's opinion make undesirable patient participate trial would jeopardize compliance wit Significant cardiovascular event ( e.g . myocardial infarction , superior vena cava [ SVC ] syndrome , New York Heart Association [ NYHA ] classification heart disease ³2 ) within 3 month entry , presence cardiac disease opinion History arrhythmia QTc Bazett 's correction unmeasurable ≥ 480 msec screening ECG</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Intrahepatic</keyword>
	<keyword>Cholangiocarcinoma</keyword>
	<keyword>Vandetanib</keyword>
	<keyword>Zactima</keyword>
	<keyword>Advanced</keyword>
	<keyword>Biliary</keyword>
	<keyword>Tract</keyword>
	<keyword>Gallbladder</keyword>
	<keyword>Extrahepatic Bile Duct</keyword>
	<keyword>Intrahepatic Cholangiocarcinoma</keyword>
	<keyword>Ampullary Carcinoma</keyword>
</DOC>